Detalhe da pesquisa
1.
Cost-Effectiveness of Cabozantinib in the Second-Line Treatment of Advanced Hepatocellular Carcinoma.
J Natl Compr Canc Netw
; 17(6): 669-675, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200357
2.
Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.
Future Oncol
; 12(23): 2755-2764, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27549331
3.
VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 151(3): 481-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25947646
4.
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma.
BMC Cancer
; 14: 592, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127891
5.
Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis.
Front Oncol
; 13: 1012783, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025595
6.
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586768
7.
Cost-effectiveness analysis of Ado-trastuzumab emtansine for the treatment of residual invasive HER2-positive breast cancer.
Einstein (Sao Paulo)
; 20: eGS6655, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544899
8.
Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA.
Immunotherapy
; 11(17): 1463-1478, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738117
9.
Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.
Einstein (Sao Paulo)
; 17(2): eGS4414, 2019 Mar 07.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-30843996
10.
Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis.
Oncotarget
; 9(14): 11805-11815, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545937
11.
Lung cancer in Brazil.
J Bras Pneumol
; 44(1): 55-64, 2018.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-29538545
12.
Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.
Einstein (Sao Paulo)
; 15(3): 349-354, 2017.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-29091159
13.
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets.
ESMO Open
; 2(3): e000200, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209522
14.
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?
J Glob Oncol
; 2(5): 292-301, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717715
15.
Disparities in cancer epidemiology and care delivery among Brazilian indigenous populations.
Einstein (Sao Paulo)
; 14(3): 330-337, 2016.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-27759820
16.
Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial.
JCO Glob Oncol
; 6: 585-588, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293940
17.
Access to cancer medications in low- and middle-income countries.
Nat Rev Clin Oncol
; 10(6): 314-22, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23568416
18.
ASCO Leadership Development Program: International Perspectives.
J Glob Oncol
; 4: 1-3, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30241270
19.
Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copies.
Expert Rev Clin Pharmacol
; 6(6): 691-701, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24147557
20.
Lung cancer in Brazil / Câncer de pulmão no Brasil
J. bras. pneumol
; 44(1): 55-64, Jan.-Feb. 2018. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-893893